DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update
09 Aug, 2023, 16:05 ET – Webcast of Earnings Call Today, August 9th at 4:30 p.m. ET – Topline data from AHFIRM trial expected in Q4 2023 CUPERTINO, Calif., Aug. 9, 2023 /PRNewswire/ — DURECT Corporation (Nasdaq: DRRX) today announced financial results for the three months ended June 30, 2023 and provided a corporate […]
DURECT Corporation Reports Second Quarter 2023 Financial Results and Business Update Read More »